( 02256.hk)
市盈率-102.27市净率1.24市销率5.31股息率0.00%上市时间2021-10-13股价4.18港币 (-9.72% , 1,433.43万港币) 市值28.41亿港币总股本6.80亿上市至今年化投资收益率-29.45%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (2): 双击编辑备注
发表讨论

和誉-B(02256) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孫洪斌Independent Non Executive Director - A/F2021-09-30--
2孫飄揚Independent Non Executive Director2021-09-30--
3王磊Independent Non Executive Director2021-09-30--
4唐豔旻Non Executive Director2021-06-10--
5葉霖Executive Director2021-01-052022-04-28
6XIA Guo Yao GavinNon Executive Director2018-10-222023-06-19
7CHEN ZhuiExecutive Director2018-03-28--
8XU Yao ChangExecutive Director2018-03-28--
9YU Hong PingExecutive Director2018-03-28--